American Society of Echocardiography (ASE)

The American Society of Echocardiography (ASE) is the key cardiovascular ultrasound medical society. ASE works to advance cardiac ultrasound, offers clinical education, research, government policy advocacy, and services to the professionals and the public.

RSS icon
Video of Hari Naidu, MD, director of the Hypertrophic Cardiomyopathy Center of Excellence at Westchester Medical Center, explaining the role of alcohol septal ablation and surgical myectomy in the era of mavacamten. #HCM #ASE

Surgery, interventional therapies still the best choice for many HCM patients

"You have to look at each patient and understand their goals," one HCM expert said in a new interview. 

HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 

Nicholas Smedira MD discusses spetal myectomy in HCM patients and the need for more detailed protocols for HCM care. #HCM #ASE #ASE2023 #myectomy

A surgeon's perspective on treating hypertrophic cardiomyopathy

Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.

Hari Naidu, MD, explains that inconsistent diagnostic imaging and how it is reported has likely led to a major underdiagnosis of HCM. #ASE #ASE2023 #HCM

Why hypertrophic cardiomyopathy may be widely underdiagnosed

One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

Anjali Owens, MD, medical director, Center for Inherited Cardiac Disease, associate professor of medicine at the Hospital of the University of Pennsylvania, discusses the need for standardization in HCM care. #ASE #ASE23 #ASE2023 #HCM

More consistency, standardization still needed when treating HCM

Anjali Owens, MD, discussed the past, present and future of hypertrophic cardiomyopathy care in the United States. "What we are aiming to do is develop a minimum standard for assessments of patients with HCM so they are getting properly diagnosed and managed," she explained. 

Lisa Salberg, CEO of the Hypertrophic Cardiomyopathy Association (HCMA) explains how the group has helped improve HCM patient care.

Hypertrophic Cardiomyopathy Association has helped advance HCM care

The Hypertrophic Cardiomyopathy Association (HCMA) has helped guide and advance HCM care not only for patients, but also for hospitals and physicians. 

FDA clears new AI to guide point-of-care cardiac ultrasound exams

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

Matt Martinez, MD, Morristown Medical Center HCM program, explains how hypertrophic cardiomyopathy patient management is changing.

Exercise plays a key part in HCM management

Matthew Martinez, MD, detailed the many ways HCM care management is changing during an exclusive interview at ASE 2023.

Displaying 25 - 32 of 90

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.